Bradley Canino

Stock Analyst at Stifel

(0)
# 4563
Out of 5,248 analysts
98
Total ratings
24.53%
Success rate
-14.26%
Average return
Main Sectors:
Top Industries:
22 Stocks
Name Action Price Target Current % Upside Ratings Updated
Janux Therapeutics
Maintains: Strong Buy
70 115
40.17 186.28% 2 Dec 3, 2024
Affimed
Maintains: Hold
5 4
1.11 260.36% 5 Nov 15, 2024
Syndax Pharmaceutica...
Maintains: Strong Buy
40 41
13.99 193.07% 5 Oct 14, 2024
Kura Oncology
Downgrades: Hold
26 19
7.86 141.73% 6 Oct 14, 2024
Celcuity
Maintains: Strong Buy
39 42
11.25 273.33% 4 Oct 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
25 40
23.5 70.21% 4 Sep 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
28 28
4.92 469.11% 4 Sep 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
115 135
81.37 65.91% 4 Sep 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
9.86 102.84% 1 Sep 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
5 3
1.79 67.6% 7 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
1.56 541.03% 1 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
32 10
2.25 344.44% 17 Jun 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
90 99
40.56 144.08% 7 Jun 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
13 14
3.71 277.36% 4 May 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
72 68
18.23 273.01% 5 May 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
40
10.52 280.23% 1 May 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
120 130
111.19 16.92% 5 Apr 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
35 55
44.16 24.55% 4 Feb 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
22 23
n/a n/a 5 Feb 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
2 10
2.6 284.62% 4 Jun 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
24
n/a n/a 1 Mar 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
50 45
n/a n/a 2 Mar 1, 2022